Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Measles Vaccine market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 2.8% during the forecast period.
This report presents the market size and development trends by detailing the Measles Vaccine market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Measles Vaccine market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Measles Vaccine industry and will help you to build a panoramic view of the industrial development.
Measles Vaccine Market, By Type:
Mumps Measles Rubella Vaccine, Live (MMR-II)
Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
Measles Vaccine Market, By Application:
Children
Adults
Some of the leading players are as follows:
CSL Limited
Johnson & Johnson
GSK
Pfizer
Sanofi-Pasteur
Novartis
Bavarian Nordic
Serum Institute of India
Medimmune
China National Biotech Group
Merck
Emergent Biosolutions
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Measles Vaccine Market: Technology Type Analysis
-
4.1 Measles Vaccine Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Measles Vaccine Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Mumps Measles Rubella Vaccine, Live (MMR-II)
4.3.2 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
5 Measles Vaccine Market: Product Analysis
-
5.1 Measles Vaccine Product Market Share Analysis, 2018 & 2026
-
5.2 Measles Vaccine Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Measles Vaccine Market: Application Analysis
-
6.1 Measles Vaccine Application Market Share Analysis, 2018 & 2026
-
6.2 Measles Vaccine Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Children
6.3.2 Adults
7 Measles Vaccine Market: Regional Analysis
-
7.1 Measles Vaccine Regional Market Share Analysis, 2018 & 2026
-
7.2 Measles Vaccine Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 CSL Limited
9.1.1 CSL Limited Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Johnson & Johnson
9.2.1 Johnson & Johnson Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 GSK
9.3.1 GSK Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Pfizer
9.4.1 Pfizer Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Sanofi-Pasteur
9.5.1 Sanofi-Pasteur Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Novartis
9.6.1 Novartis Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Bavarian Nordic
9.7.1 Bavarian Nordic Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Serum Institute of India
9.8.1 Serum Institute of India Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Medimmune
9.9.1 Medimmune Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 China National Biotech Group
9.10.1 China National Biotech Group Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Merck
9.11.1 Merck Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 Emergent Biosolutions
9.12.1 Emergent Biosolutions Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
The List of Tables and Figures (Totals 92 Figures and 127 Tables)
Figure Mumps Measles Rubella Vaccine, Live (MMR-II) Measles Vaccine market, 2015 - 2026 (USD Million)
Figure Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) Measles Vaccine market, 2015 - 2026 (USD Million)
Figure Children market, 2015 - 2026 (USD Million)
Figure Adults market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Measles Vaccine market, by country, 2015 - 2026 (USD Million)
-
Table North America Measles Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table North America Measles Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table North America Measles Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Measles Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Measles Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Measles Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Measles Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Canada Measles Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Canada Measles Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Europe Measles Vaccine market, by country, 2015 - 2026 (USD Million)
-
Table Europe Measles Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Europe Measles Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Europe Measles Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Measles Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Measles Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Measles Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Measles Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Germany Measles Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Germany Measles Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Measles Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table France Measles Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table France Measles Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Measles Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Italy Measles Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Italy Measles Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Measles Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Spain Measles Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Spain Measles Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Measles Vaccine market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Measles Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Measles Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Measles Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Measles Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table China Measles Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table China Measles Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Measles Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Japan Measles Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Japan Measles Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Measles Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table India Measles Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table India Measles Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Measles Vaccine market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Measles Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Measles Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Measles Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Measles Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Measles Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Measles Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Measles Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Measles Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Measles Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Measles Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Measles Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Measles Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table MEA Measles Vaccine market, by country, 2015 - 2026 (USD Million)
-
Table MEA Measles Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table MEA Measles Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table MEA Measles Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Measles Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Measles Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Measles Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Measles Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Measles Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Measles Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table CSL Limited Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table GSK Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Pfizer Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sanofi-Pasteur Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Novartis Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Bavarian Nordic Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Serum Institute of India Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Medimmune Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table China National Biotech Group Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Merck Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Emergent Biosolutions Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
